LENSAR, Inc. (LNSR)
About LENSAR, Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $51.7M
- Net income
- -$34.3M
- Total assets
- $71.4M
- Market cap
- $67.8M
- Gross margin
- 46.4%
- Operating margin
- -42.1%
- Net margin
- -58.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $58.4M
- Cost of revenue
- $31.3M
- Gross profit
- $27.1M
- Operating expenses
- $51.7M
- Operating income
- -$24.6M
- Net income
- -$34.3M
- EPS (basic)
- $-2.87
- EPS (diluted)
- $-2.87
Balance sheet
- Total assets
- $71.4M
- Current assets
- $46.8M
- Total liabilities
- $83.7M
- Current liabilities
- $40.6M
- Shareholders’ equity
- -$26.0M
Cash flow
- Operating cash flow
- -$14.8M
- Investing cash flow
- $1.3M
- Financing cash flow
- $10.3M
- Net cash flow
- -$3.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $67.8M
- EPS (diluted)
- $-2.87
- Shares outstanding
- 12.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 21, 2020
LENSAR, Inc. (LNSR) Stock Price
- Reported a net loss of $34.3M in FY2025.
- Revenue grew 121% from FY2020 to FY2025.
- Gross margin of 46.4%, net margin -58.7%.
- Trading 58% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review LENSAR, Inc..
Write a review
News about LENSAR, Inc.
News & sentiment via Polygon.io
LENSAR, Inc.: frequently asked questions
Is LENSAR, Inc. an American company?
LENSAR, Inc. is a US-based company headquartered in Orlando, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is LENSAR, Inc. headquartered?
LENSAR, Inc. is headquartered in Orlando, Florida, United States.
Is LENSAR, Inc. publicly traded?
Yes — LENSAR, Inc. is a publicly traded company. Its stock trades under the ticker symbol LNSR on the NASDAQ.
What does LENSAR, Inc. do?
LENSAR, Inc. is an American Medical Devices company in the Health & Beauty sector.
